« Back to Record
Citation APA

Agostinetto, E., Ameye, L., Martel, S., Aftimos, P., Pondé, N., Maurer, C., El-abed, S., Wang, Y., Vicente, M., Chumsri, S., Bliss, J. M., Kroep, J., Colleoni, M. A., Petrelli, F., Del Mastro, L., Moreno-Aspitia, A., Piccart-Gebhart, M., Paesmans, M., de Azambuja, E., & Lambertini, M. (2022). PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. NPJ breast cancer, 8(1), 87. doi:10.1038/s41523-022-00452-8


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/346856

Agostinetto, E., Ameye, L., Martel, S., Aftimos, P., Pondé, N., Maurer, C., El-abed, S., Wang, Y., Vicente, M., Chumsri, S., Bliss, J. M., Kroep, J., Colleoni, M. A., Petrelli, F., Del Mastro, L., Moreno-Aspitia, A., Piccart-Gebhart, M., Paesmans, M., de Azambuja, E., & Lambertini, M. (2022). PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer. NPJ breast cancer, 8(1), 87. doi:10.1038/s41523-022-00452-8